Ranitidine and other H2-receptor antagonists: recent developments.
D000818:Animals; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D005260:Female; D005663:Furans / Q000494:pharmacology; D005744:Gastric Acid / Q000378:metabolism; D005753:Gastric Mucosa / Q000187:drug effects; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006635:Histamine H2 Antagonists / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D066298:In Vitro Techniques; D051379:Mice; D011899:Ranitidine / Q000494:pharmacology* / Q000627:therapeutic use; D051381:Rats; D011970:Receptors, Histamine H2 / Q000187:drug effects; D013329:Structure-Activity Relationship; D014599:Uterus / Q000187:drug effects
D005663:Furans; D006635:Histamine H2 Antagonists; D007093:Imidazoles; D011970:Receptors, Histamine H2; D011899:Ranitidine